A rare Bundibugyo virus outbreak in Congo, with over 200 deaths, lacks specific treatments or vaccines, complicating response efforts. Whil...

Tactical investing should not be confused with long-term investing. In a world where geopolitical risk, commodity shocks, and uncertainty a...

A study published in the journal Nature has found a link between the COVID-19 antiviral drug molnupiravir and a pattern of mutations in the...

During the past two years, there were sky-rocketing sales of Covid-19 portfolio of drugs, sometimes even severe shortages. But now the indu...

"Identifying combinations of antivirals is really important, not only because doing so may increase the drugs' potency against the coronavi...

Generic molnupiravir will increase access in India and other low- and middle-income countries (LMICs), while simplifying current supply cha...

The Drug Controller General of India had last week approved Merck and Ridgeback’s antiviral molnupiravir for the treatment of mild-to-moder...

The company has begun investing $1 billion, at risk, in the manufacture of its potential Covid-19 oral antiviral drug with the goal of maki...

"This launch is yet another step in our endeavour to enable access to all treatments in COVID care. We continue to be guided by the power o...

Data from Pfizer's clinical trial showed its two-drug antiviral regimen was 90% effective in preventing hospitalizations and deaths in pati...

UK approved molnupiravir, the COVID antiviral developed by Merck and Ridgeback Therapeutics. Now, Pfizer has released results from trials o...

In a meeting held on October 4, both the companies said that they “they want to discontinue phase III trial in moderate Covid-19 patients a...

The researchers noted that this does not necessarily mean that the combination works in humans, but could be a hot tip for researchers who ...

One promising drug that could improve things is molnupiravir, an antiviral that's moving into the final stages of testing in humans. Resear...

It triggers a response against three major types of human respiratory viruses, including Covid.

Aside from drugs, doctors have learned more about ways to treat hospitalized patients.

The study, published in the journal Pathogens, found that all four drugs were effective in inhibiting, or blocking, the coronavirus' RNA pr...